COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)

This trial will evaluate several COVID-19 vaccine candidates for safety and their ability to generate an immune response.

Participants must be 18 years of age or older. 

Sponsor(s)
National Institute of Allergy and Infectious Diseases (NIAID)
Principal Investigator(s)
Dr. David Diemert, MD/Medicine & Microbiology, Immunology and Tropical Medicine
Contact Phone Number
Request Information